How DecisionDx-Melanoma works and data supporting it

Precision Oncology: DecisionDx®-Melanoma and the Evolution of GEP Testing in Cutaneous MelanomaПодробнее

The Data that Supports the DecisionDx®-Melanoma Test is StrongПодробнее

How Advocating for Myself Led to Essential Insights with the DecisionDx-Melanoma TestПодробнее

How DecisionDx-Melanoma Guides Pre- and Post-Operative Care: Insights from Surgical OncologistПодробнее

How DecisionDx-Melanoma Predicts Tumor Behavior: How a Dermatologist Explains the Test to PatientsПодробнее

How DecisionDx-Melanoma Supports Sentinel Biopsy Decisions: Insights from Dr. Shannon TrotterПодробнее

The DecisionDx®-Melanoma Test Complements Current Melanoma StagingПодробнее

New data for DecisionDx-MelanomaПодробнее

Dr. Moody - Advances in Cutaneous MelanomaПодробнее

How DecisionDx-Melanoma Enhances Patient Management: Insights from Dr. Neil FernandezПодробнее

DecisionDx®-Melanoma Provides the Future of Melanoma Prognosis for Patient, TodayПодробнее

How DecisionDx-Melanoma Personalizes Skin Cancer Care: Dr. Shannon Trotter ExplainsПодробнее

What is DecisionDx-Melanoma?Подробнее

Managing High-Risk Melanoma Patients Using the DecisionDx-Melanoma. A Dermatologist Explains HowПодробнее

How the DecisionDx-Melanoma Test Can Impact Your Melanoma Treatment Plan: Beyond a Regular BiopsyПодробнее

How does the DecisionDx-Melanoma test work?Подробнее

DecisionDx-Melanoma Linked to Improved Outcomes: Hear a Dermatologist Explain SEER Data InsightsПодробнее

How DecisionDx-Melanoma Identifies High-Risk Patients in Low-Risk Melanoma CasesПодробнее